CGEN
Compugen Ltd.NASDAQHealthcare$2.26-3.54%ClosedMarket Cap: $213.7M
As of 2026-04-06
Valuation
P/E (TTM)
6.05
PEG
0.02
P/B
2.00
P/S
2.83
EV/EBITDA
3.55
DCF Value
$-12.95
FCF Yield
15.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
87.3%
Operating Margin
43.1%
Net Margin
48.6%
ROE
55.7%
ROA
22.5%
ROIC
23.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $67.3M | 94.7% | $56.0M | $56.8M | $0.60 | — |
| FY 2025 | $72.8M | 87.3% | $31.3M | $35.3M | $0.38 | — |
| Q3 2025 | $1.9M | 12.7% | $-7.9M | $-7.0M | $-0.07 | — |
| Q2 2025 | $1.3M | -32.5% | $-8.4M | $-7.3M | $-0.08 | — |
| Q1 2025 | $2.3M | -5.1% | $-8.4M | $-7.2M | $-0.08 | — |
| Q4 2024 | $1.5M | 54.1% | $-7.5M | $-6.1M | $-0.07 | — |
| FY 2024 | $27.9M | 71.5% | $-14.9M | $-14.2M | $-0.16 | — |
| Q3 2024 | $17.1M | 79.0% | $4.5M | $1.3M | $0.01 | — |
| Q2 2024 | $6.7M | 76.8% | $-3.4M | $-2.1M | $-0.02 | — |
| Q1 2024 | $2.6M | 17.9% | $-8.5M | $-7.3M | $-0.08 | — |
| Q4 2023 | $33.5M | 94.0% | $18.0M | $9.7M | $0.11 | — |
| FY 2023 | $33.5M | 94.0% | $-13.0M | $-18.8M | $-0.21 | — |